Welcome! Login | Register
 

Man Shot in Leg During Fight in Worcester—Man Shot in Leg During Fight in Worcester

Weather Update: Snow Expected to Hit Worcester’s Monday Morning Commute—Weather Update: Up to 2 Inches of Snow…

Fecteau: Trump’s Big Business Boondoggle—Fecteau: Trump’s Big Business Boondoggle

Brady Becomes All-Time Winningest QB, Patriots Cruise Past Rams 26-10—Brady Becomes All-Time Winningest QB, Patriots Cruise Past…

Smart Benefits: USCIS Unveils New Form I-9—Smart Benefits: USCIS Unveils New Form I-9

College Admissions: Why GPA’s Lie—Do you know what they're doing with your…

Luca + Danni: An Amazing New Jewelry Company—Luca + Danni: An Amazing New Jewelry Company

“The Sunday Political Brunch”—December 4, 2016—“The Sunday Political Brunch” -- December 4, 2016

Parent Pleads to Have Memes Using Son’s Image Taken Down from Internet—Parent Pleads to Have Memes Using Son’s Image…

Leonard Moorehead the Urban Gardener: “Scent, First and Last”—Crisp cool mornings tighten their grip.

 
 

AG Announces $68.5 Million Settlement with AstraZeneca

Friday, March 11, 2011

 

Attorney General Peter Kilmartin announced today that a $68.5 million dollar settlement has been reached with AstraZeneca Pharmaceuticals.

This settlement, which is the largest ever multi-state consumer protection-based pharmaceutical settlement, is expected to bring $908,838 to the state.

The settlement stems from a complaint alleging that AstraZeneca used deceptive practices to market the antipsychotic drug Seroquel for off-label uses, according to the Attorney General. The company was accused of withholding information on the drug’s dangerous potential side effects, in addition to the negative results of scientific study done that tested the safety of the drug.

“This settlement shows the commitment of this office to protect consumers from deceptive marketing and advertising practices by big pharmaceutical companies,” Kilmartin said.

Company promises changes

AstraZeneca has promised to alter the way that it markets Seroquel, eliminating the misleading practices in question. Along with the $68.5 million payment, under the settlement AstraZeneca must comply with provisions addressing numerous concerns that an extensive 3-year investigation yielded. For example, AstraZeneca must have policies in place to ensure that sales personnel do not promote to health care providers who are unlikely to prescribe Seroquel for an FDA-approved use.

Other states participating in the investigation and settlement were: Florida, Illinois, Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Vermont, Washington, West Virginia and Wisconsin.
 

 

Enjoy this post? Share it with others.

 
Delivered Free Every
Day to Your Inbox